Clinical Strategies and Comprehensive Updates for State-of-the-Art Endocrine Care
April 3 – 7, 2024
Harvard Clinical Endocrinology 2024,
Education to Optimize Care of Patients with Endocrine Disorders
You can rely on this program to enhance your endocrine knowledge and optimize your care of endocrine disorders with evidence-based strategies. This course provides:
- Improved screening for common conditions
- The newest clinical guidelines, including the new guidelines for primary hyperparathyroidism and hypoparathyroidism
- Expanded options for diagnosis
- State-of-the-art treatment strategies
- Guidance for challenging cases
- Updates for management of common and rare endocrine disorders
- New concepts in endocrinology and diabetes
- Pediatric endocrinology updates
- Skills advancement workshops, including thyroid ultrasound, insulin pump management, and continuous glucose monitoring (CGM)
- Dedicated time to pose your specific questions to experts
A Practical, Comprehensive Update for Busy Clinicians
This program delivers comprehensive updates to improve screening, evaluation, diagnosis, and treatment of:
- Pituitary lesions
- Pituitary hormone excess and hypopituitarism
- Adrenal conditions and incidentalomas
- Male and female reproductive conditions
- Calcium/bone disorders, including osteoporosis
- Thyroid nodules, hyper- and hypothyroidism
- Diabetes: type 1, type 2, and in pregnancy
- Obesity
- Lipid disorders
Our faculty, world renowned for their clinical, research, and teaching achievements, cover important updates and recent advances for a broad array of endocrine conditions:
- Acromegaly
- Adrenal incidentaloma
- Adult growth hormone deficiency
- Cushing’s disease
- Diabetes in pregnancy
- Diabetes type 1
- Diabetes type 2
- Erectile dysfunction
- Gestational diabetes
- Glucocorticoid-induced osteoporosis
- Graves’ eye disease
- Hyper- and hypoparathyroidism
- Hyper- and hypothyroidism
- Hyperprolactinemia
- Hypo- and hypercalcemia
- Hypoglycemia
- Hypopituitarism
- Insulin pumps, continuous glucose monitoring (CGM), and technology management in type 1 DM
- Lipid disorders
- Male and female hypogonadism
- Menopause
- Obesity/weight management
- Osteoporosis
- Pheochromocytoma
- Pituitary surgery and radiation
- Polycystic ovarian syndrome/hyperandrogenism
- Primary aldosteronism
- Sellar region abnormalities
- Thyroid cancer
- Thyroid disease and pregnancy
- Thyroid nodules
- Thyroid ultrasound
- Transgender care
